Search

everythinglearnresearchcommunity

for

Search:↓

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Tamoxifen effectively treats gynecomastia without causing impotence.

Endocrine therapies for cancer significantly increase the risk of hair loss.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Low-dose oral minoxidil effectively treats female hair loss with good safety.

Hand preference and sexual orientation may predict finasteride side effects in male hair loss.

Finasteride effectively and safely treats recurrent priapism in children and adolescents with sickle cell disease.

Certain Dibenzo derivatives may help treat prostate cancer.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Some dibenzo compounds might help treat cancer with fewer side effects.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

There is no significant link between insulin resistance and certain hair disorders like idiopathic hirsutism and androgenic alopecia.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Hair loss is a common side effect of hormone treatments for cancer.

Finasteride helps hair growth and prostate issues but may cause sexual side effects and increase tumor risk.

Minoxidil and pyrithione zinc combo most effectively increases hair density.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

Genetic variations affecting skin structure play a key role in severe acne.

Mutations in the WNT10A gene can cause skin, hair, teeth, and other disorders, and may also affect other areas like kidney and cancer, with potential for targeted treatments.

FOXN1 mutations can cause varying immune and physical issues, with severity influenced by gene activity and possibly other factors.

Minoxidil reduces lysine hydroxylase in skin cells.

New guidelines stress early diagnosis and lifestyle changes to manage metabolic syndrome and prevent complications.

Longer GGN repeats in the androgen receptor gene are linked to polycystic ovary syndrome.

A compound from brown algae boosts the production of a certain inflammatory substance in skin cells.